Key facts
- Manuals
- 1
- Languages
- JA
- Last added
- 2012-02-23
Featured JLY-C28LT manuals

JLY-C28LT makeuse security Manual
The document announces a series of changes aimed at preventing medical‑related accidents, including a new sales name, updated packaging, and revised labeling for the Estriol Injection. It references regulatory notices from the Ministry of Health, Labour and Welfare and outlines the timeline for the new packaging rollout.
Specific updates include the adoption of a new top‑opening box with perforations for easier disposal, addition of barcode information (sales‑packaging unit code and dispensing‑packaging unit code), and the inclusion of the sales company name (Takeda Pharmaceutical Co., Ltd.) on the packaging and accompanying documents. Contact details for ASKA Pharmaceutical’s medical‑information office are also provided. This manual is written in Japanese.
Covers: Sales Name Change · Packaging Update · Barcode and Code Information · Regulatory References · Contact Information
Latest JLY-C28LT manuals
JLY-C28LT makeuse security Manual
Product Leaflet 4 pages · 284 KB · JAThis leaflet explains the packaging, labeling, and sales‑name changes for ASKA Pharmaceutical's Estriol Injection.
Questions answered in JLY-C28LT manuals
When will the new packaging be available?
The new packaging will be supplied from July 2008 onward.
Which company is listed as the sales company on the new packaging?
Takeda Pharmaceutical Co., Ltd. is shown as the sales company.
